Pharma Journalist -

Bristol Myers Squibb announced that the European Commission (EC) has granted approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR)…
Read More...

BrightPath Biotherapeutics Co., Ltd., a clinical stage biotechnology company focused on the development of cell therapies derived from invariant natural killer T (iNKT) cells, and…
Read More...

Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in…
Read More...

Our health system exists to allow all people to fulfill their human potential. Now, the challenge of undoing a legacy of systemic disparities falls on a our shoulders as we continue to…
Read More...

Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong…
Read More...

ALX Oncology Holdings Inc. announced it has entered into a clinical trial collaboration and supply agreement with Sanofi to evaluate the combination of evorpacept, a next generation…
Read More...

Lantheus Holdings, Inc. and POINT Biopharma Global, Inc. announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for 177Lu-PNT2002 for the treatment of…
Read More...

Oncotelic Therapeutics, Inc. announced a strategic partnership with Vectara, a company specializing in innovative Natural Language Understanding (NLU) technologies, to accelerate the…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab),…
Read More...

ANGLE plc is delighted to announce it has signed an agreement with BioView Ltd. ("BioView") (BIOV.TA) to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast…
Read More...